| 5-HT2C receptor agonists: pharmacological characteristics and therapeutic potential JR Martin, M Bös, F Jenck, JL Moreau, V Mutel, AJ Sleight, J Wichmann, ... The Journal of pharmacology and experimental therapeutics 286 (2), 913-924, 1998 | 415 | 1998 |
| Drug-induced stimulation and suppression of action monitoring in healthy volunteers ERA De Bruijn, W Hulstijn, RJ Verkes, GSF Ruigt, BGC Sabbe Psychopharmacology 177, 151-160, 2004 | 301 | 2004 |
| Changes in sleep architecture following chronic mild stress S Cheeta, G Ruigt, J Van Proosdij, P Willner Biological psychiatry 41 (4), 419-427, 1997 | 250 | 1997 |
| Effects of antipsychotic and antidepressant drugs on action monitoring in healthy volunteers ERA De Bruijn, BGC Sabbe, W Hulstijn, GSF Ruigt, RJ Verkes Brain research 1105 (1), 122-129, 2006 | 194 | 2006 |
| Guidelines for the recording and evaluation of pharmaco-EEG data in man: the International Pharmaco-EEG Society (IPEG) M Jobert, FJ Wilson, GSF Ruigt, M Brunovsky, LS Prichep, ... Neuropsychobiology 66 (4), 201-220, 2012 | 174 | 2012 |
| Efficacy of mirtazapine in obstructive sleep apnea syndrome DW Carley, C Olopade, GS Ruigt, M Radulovacki Sleep 30 (1), 35-41, 2007 | 145 | 2007 |
| Effect of the antidepressant Org 3770 on human sleep GSF Ruigt, B Kemp, CM Groenhout, HAC Kamphuisen European journal of clinical pharmacology 38, 551-554, 1990 | 144 | 1990 |
| Rapid glucocorticoid receptor-mediated inhibition of hypothalamic–pituitary–adrenal ultradian activity in healthy males GM Russell, DE Henley, J Leendertz, JA Douthwaite, SA Wood, ... Journal of Neuroscience 30 (17), 6106-6115, 2010 | 134 | 2010 |
| Pyrethroids GSF Ruigt Comprehensive insect physiology, biochemistry and pharmacology 12, 183-262, 1985 | 127 | 1985 |
| Acute effects of the ampakine farampator on memory and information processing in healthy elderly volunteers E Wezenberg, R Jan Verkes, GSF Ruigt, W Hulstijn, BGC Sabbe Neuropsychopharmacology 32 (6), 1272-1283, 2007 | 126 | 2007 |
| The α2‐selective adrenoceptor antagonist org 3770 (mirtazapine, Remeron®) enhances noradrenergic and serotonergic transmission T De Boer, GSF Ruigt, HHG Berendsen Human Psychopharmacology: Clinical and Experimental 10 (S2), S107-S118, 1995 | 103 | 1995 |
| Behavioural and electrophysiological studies of entorhinal cortex lesions in the rat JJ Hagan, EE Verheijck, MH Spigt, GSF Ruigt Physiology & behavior 51 (2), 255-266, 1992 | 101 | 1992 |
| The Selective α2-Adrenoceptor Antagonist Mirtazapine (Org 3770) Enhances Noradrenergic and 5-HT1A-Mediated Serotonergic Neurotransmission T de Boer, GSF Ruigt CNS drugs 4 (Suppl 1), 29-38, 1995 | 96 | 1995 |
| Modulation of memory and visuospatial processes by biperiden and rivastigmine in elderly healthy subjects E Wezenberg, RJ Verkes, BGC Sabbe, GSF Ruigt, W Hulstijn Psychopharmacology 181, 582-594, 2005 | 86 | 2005 |
| Lysophosphatidic acid induces inward currents in Xenopuslaevis oocytes; evidence for an extracellular site of action BJH Fernhout, FA Dijcks, WH Moolenaar, GSF Ruigt European journal of pharmacology 213 (2), 313-315, 1992 | 83 | 1992 |
| Pharmaco-EEG studies in animals: an overview of contemporary translational applications WHIM Drinkenburg, GSF Ruigt, A Ahnaou Neuropsychobiology 72 (3-4), 151-164, 2016 | 77* | 2016 |
| Examination of Org 26576, an AMPA receptor positive allosteric modulator, in patients diagnosed with major depressive disorder: an exploratory, randomized, double-blind … KR Nations, P Dogterom, R Bursi, J Schipper, S Greenwald, D Zraket, ... Journal of psychopharmacology 26 (12), 1525-1539, 2012 | 71 | 2012 |
| Pain cognition versus pain intensity in patients with endometriosis: toward personalized treatment MAW van Aken, JM Oosterman, CM Van Rijn, MA Ferdek, GSF Ruigt, ... Fertility and Sterility 108 (4), 679-686, 2017 | 68 | 2017 |
| Psychomotor and memory effects of haloperidol, olanzapine, and paroxetine in healthy subjects after short-term administration M Morrens, E Wezenberg, RJ Verkes, W Hulstijn, GSF Ruigt, BGC Sabbe Journal of clinical psychopharmacology 27 (1), 15-21, 2007 | 65 | 2007 |
| Pharmacokinetic-pharmacodynamic model for the reversal of neuromuscular blockade by sugammadex. BA Ploeger, J Smeets, A Strougo, HJ Drenth, G Ruigt, N Houwing, ... Anesthesiology 110 (1), 95-105, 2009 | 64 | 2009 |